HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B Pegourie-Bandelier Selected Research

1- arabinofuranosylcytosine- 5'- stearylphosphate

4/2002Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B Pegourie-Bandelier Research Topics

Disease

1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2002

Drug/Important Bio-Agent (IBA)

11- arabinofuranosylcytosine- 5'- stearylphosphateIBA
04/2002
1InterferonsIBA
04/2002